Not Signed In - FDA wants ADHD drugs to carry patient advisory guides on risks
Thu, 22 Feb 2007 10:26 AM EST
... Manufacturers of drugs used in the treatment of attention deficit hyperactivity disorder (ADHD) have been directed by health officials to introduce additional guidance to patients on the risks of cardiovascular and psychiatric diseases possible through the use of these drugs. ...
Related Topics
- Patient Issues
- Personal Medical Records
- Dietary Guidelines
- ADHD
- Bioethics
- Medication
- Amniocentesis
- Tacrolimus ointment
- Guanfacine
- Mammography
- Travel Health
- Anticancer Drugs
- Carcinogens
- Neuropathy secondary to drugs
- Date Rape Drugs
- Side effects from drugs such as amphotericin B
- Disease-modifying anti-rheumatoid drugs
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Kidney impairment (from drugs used to treat the condition)
- Low white blood cell count (from drugs used to treat the condition)
email this page
print this page
bookmark this page
feedback on this page
